Join the club for FREE to access the whole archive and other member benefits.

Philip Low

Chairman, CEO and Founder at NeuroVigil.

Dr. Low made his first scientific discovery at Harvard Medical School – as a teenager. While inventing new brain monitoring techniques at the University of Chicago, he was referred to the Salk Institute by Francis Crick, Nobel Laureate of DNA fame, where he authored a 1 page PhD thesis on dynamic brain activity mapping unanimously approved by a committee of two past presidents of the Society for Neuroscience (SfN) and four members of the National Academy of Sciences, including his co-advisors, Drs. Terry Sejnowski and Fred Gage. The thesis work led to his creation of NeuroVigil, the neurotechnology company responsible for iBrainTM, a portable brain activity monitor, with first and second round valuations two and two-and-a-half times Google’s and Facebook’s combined, respectively, as well as to his writing of the Cambridge Declaration on Consciousness, the first formal document officially recognizing consciousness in non-humans – by demonstrating that features thought to be at best unique to the human brain were not necessary for features for which consciousness is thought to be necessary – the signing of which by neuroscientists was described as a “Copernican moment in the history of civilization” which has led to a worldwide debate and to the evolution of the treatment and rights of non-humans.

Visit website: https://neurovigil.com/index.php/about-us/leadership

 dr-philip-low-b742ba

 DrPhilipLow

See also: Company NeuroVigil - Neurotechnology company focused on the analysis of brain signal or EEG data.

Details last updated 20-Jun-2020

Philip Low News

Exponential Medicine conference day 3 summary

Exponential Medicine conference day 3 summary

Medgadget - 13-Nov-2015

Practice of medicine needs to become the science of medicine Regenerative and Rejuvenative Medic...